TrialClinical, cosmetic and investigational dermatology2021

Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial.

Janet DuBois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.